Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clenbuterol in Adult Pompe Disease
NCT04094948Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- Jan 2023
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of clenbuterol in Pompe disease, sponsored by Duke University. Planned start Jan 2023; status: withdrawn.
02
Drugs
clenbuterol
03
Conditions
Pompe disease
Beyond the preview
Go deeper on NCT04094948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04094948.